Citadel Advisors’s Mineralys Therapeutics MLYS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $195K | Sell |
14,382
-129,980
| -90% | -$1.76M | ﹤0.01% | 5015 |
|
|
2025
Q1 | $2.29M | Buy |
+144,362
| New | +$2.29M | ﹤0.01% | 2470 |
|
|
2024
Q4 | – | Sell |
-3,136
| Closed | -$38K | – | 6471 |
|
|
2024
Q3 | $38K | Sell |
3,136
-9,898
| -76% | -$120K | ﹤0.01% | 5186 |
|
|
2024
Q2 | $152K | Buy |
13,034
+12,937
| +13,337% | +$151K | ﹤0.01% | 4777 |
|
|
2024
Q1 | $1.25K | Sell |
97
-115,206
| -100% | -$1.49M | ﹤0.01% | 5904 |
|
|
2023
Q4 | $992K | Buy |
115,303
+96,687
| +519% | +$832K | ﹤0.01% | 3041 |
|
|
2023
Q3 | $177K | Buy |
+18,616
| New | +$177K | ﹤0.01% | 4612 |
|
|
2023
Q2 | – | Sell |
-191,048
| Closed | -$2.99M | – | 6217 |
|
|
2023
Q1 | $2.99M | Buy |
+191,048
| New | +$2.99M | ﹤0.01% | 2183 |
|